0001209191-21-003245.txt : 20210112 0001209191-21-003245.hdr.sgml : 20210112 20210112163548 ACCESSION NUMBER: 0001209191-21-003245 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210108 FILED AS OF DATE: 20210112 DATE AS OF CHANGE: 20210112 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Buck Jill CENTRAL INDEX KEY: 0001780426 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33038 FILM NUMBER: 21523901 MAIL ADDRESS: STREET 1: C/O ZIOPHARM ONCOLOGY, INC. STREET 2: ONE FIRST AVENUE, PARRIS BUILDING 34 CITY: BOSTON STATE: MA ZIP: 02129 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ZIOPHARM ONCOLOGY INC CENTRAL INDEX KEY: 0001107421 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 841475642 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE FIRST AVENUE STREET 2: PARRIS BUILDING 34, NAVY YARD PLAZA CITY: BOSTON STATE: MA ZIP: 02129 BUSINESS PHONE: 617-259-1970 MAIL ADDRESS: STREET 1: ONE FIRST AVENUE STREET 2: PARRIS BUILDING 34, NAVY YARD PLAZA CITY: BOSTON STATE: MA ZIP: 02129 FORMER COMPANY: FORMER CONFORMED NAME: EASYWEB INC DATE OF NAME CHANGE: 20010213 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-01-08 0 0001107421 ZIOPHARM ONCOLOGY INC ZIOP 0001780426 Buck Jill ONE FIRST AVENUE, PARRIS BUILDING 34 NAVY YARD PLAZA BOSTON MA 02129 0 1 0 0 EVP, GM Gene Therapy Common Stock 2021-01-08 4 S 0 27894 3.12 D 199516 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person to satisfy withholding tax obligations upon the vesting of restricted stock grants. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.035 to $3.205, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ Robert Hadfield, Attorney-in-Fact 2021-01-12